Review
doi: 10.1093/ndt/10.supp2.35.
Starting r-HuEPO in chronic renal failure: when, why, and how?
Affiliations
- PMID: 7644104
- DOI: 10.1093/ndt/10.supp2.35
Item in Clipboard
Review
Starting r-HuEPO in chronic renal failure: when, why, and how?
Nephrol Dial Transplant.
1995.
No abstract available
Similar articles
-
[The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].Schweiz Med Wochenschr. 1990 Feb 17;120(7):217-20. Schweiz Med Wochenschr. 1990. PMID: 2309110 German.
-
Starting r-HuEPO in chronic renal failure: when, why, and how?Nephrol Dial Transplant. 1995;10 Suppl 2:43-7. doi: 10.1093/ndt/10.supp2.43. Nephrol Dial Transplant. 1995. PMID: 7644105
-
Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.Drugs. 1989 Sep;38(3):342-5. doi: 10.2165/00003495-198938030-00002. Drugs. 1989. PMID: 2806134 No abstract available.
-
Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous.Acta Haematol. 1992;87 Suppl 1:16-9. doi: 10.1159/000204783. Acta Haematol. 1992. PMID: 1574961 Review.
-
Erythropoietin therapy in patients with chronic renal failure.West J Med. 1992 Aug;157(2):154-7. West J Med. 1992. PMID: 1441466 Free PMC article. Review.
Cited by
-
Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure.Drugs. 1996 Feb;51(2):299-318. doi: 10.2165/00003495-199651020-00008. Drugs. 1996. PMID: 8808169 Review.
-
Subcutaneous r-HuEPO therapy in CAPD patients: dose determination and clinical experience.Int Urol Nephrol. 1998;30(1):91-7. doi: 10.1007/BF02550285. Int Urol Nephrol. 1998. PMID: 9569119 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
